Volume 23, Number 10—October 2017
Research Letter
Fluoroquinolone-Resistant Alcaligenes faecalis Related to Chronic Suppurative Otitis Media, Angola
Abstract
We found that 20 (10.6%) of 188 patients with chronic suppurative otitis media in Angola were co-colonized with fluoroquinolone-resistant Alcaligenes faecalis, commonly found in birds. A likely explanation for our findings was the use of bird feces by residents as a traditional remedy to prevent ear secretions caused by primary ear infection.
Chronic suppurative otitis media (CSOM) is a common condition in developing countries and in original populations such as the Inuit (1). Mainly, young children are reported to have CSOM; 30%–40% of the population are affected in some geographic areas (2). CSOM is associated with hearing loss caused by perforation of the tympanic membrane, which often leads to chronic infection of the middle ear. Overcrowding, poor hygiene, and low nutrition status, in addition to absence of modern healthcare systems, are contributing factors for CSOM (2). CSOM is caused by a polymicrobial infection including gram-negative species, dominated by Pseudomonas aeruginosa and Proteus mirabilis, in addition to gram-positive bacteria such as enterococci and staphylococci (3).
During studies of ear disharge caused by otitis media, we detected the gram-negative bacillus Alcaligenes faecalis in addition to the commonly isolated bacterial species (3). A. faecalis may reside in the human microbiome of the gastrointestinal tract but only occasionally causes disease. Most cases occur in immunocompromised hosts, but in rare instances, A. faecalis infection has been described in patients who had acute otitis media, peritonitis, and eye or urinary tract infections (4–6). A. faecalis is frequently found in bird fecal specimens and can also cause opportunistic infections in these animals (7).
We examined specimens from 188 patients who had ear discharge related to otitis media who attended an outpatient ear, nose, and throat clinic in Luanda, Angola, during January–December 2016. This study was approved by the Angolan Medical Council, the director of the Josína Machel Hospital, and the Luanda University Medical Faculty. After cleaning the ear canal with 70% ethanol, we collected discharge with a swab. For nasopharyngeal sampling, we inserted a swab into the nostril past the choana and touched the wall of the nasopharynx. We collected ear and nasopharyngeal samples and stored them in skim milk-tryptone-glucose-glycerol (STGG) medium (8) at −70°C (Public Health Laboratory, Luanda, Angola) before transport to the Riesbeck Laboratory (Malmö, Sweden). Clinical specimens were cultured and bacteria analyzed (Technical Appendix). We found that 20 (10.6%) patients were colonized by A. faecalis (Table). Among patients harboring A. faecalis, 14 were male (1–47 years of age) and 6 were female (2–23 years of age). A. faecalis was growing in polymicrobial communities, and P. aeruginosa was the predominant species in 10 (50%) of the patients. Proteus mirabilis was the second most common bacterium (n = 7), followed by Klebsiella spp. and gram-positive cocci. Eight of the patients had otalgia, and the duration of otorrhoea was >12 months in 4 of those patients.
We tested A. faecalis isolates against a series of selected antimicrobial drugs by using broth microdilution (Technical Appendix Table) and found 100% were susceptible to aminoglycoside amikacin, cephalosporins, and colistin. In addition, 90% were susceptible to gentamicin, tobramycin, and piperacillin/tazobactam, and 75% were susceptible to trimethoprim/sulfamethoxazole. By contrast, most isolates were resistant to the fluoroquinolones ciprofloxacin (100%) and levofloxacin (82.6%).
A. faecalis has been described in patients with CSOM (9), but for us, this observation was initially an enigma. We considered the possibility of a contaminant from the endogenous fecal microbiome. We found, however, that to prevent ear discharge, patients occasionally filled their external auditory canals with dove or pigeon feces. Some patients in the geographic area also used cockroach paste, palm oil, sweet olive oil, sewing machine oil, or breast milk to prevent ear discharge. The origin of A. faecalis from birds would be a likely explanation for the appearance of this particular bacterial species among this study cohort.
Topical treatment using antimicrobial drugs in combination with keeping the ear canal clean and dry is the mainstay of therapy for CSOM (10). It remains to be confirmed whether A. faecalis colonization plays a crucial role for disease progression or merely is a contaminant. However, the microbiological findings in this study should be a note of caution because all A. faecalis isolates we obtained were resistant against the most commonly used fluoroquinolone, ciprofloxacin. An alternative strategy would therefore be to consider colistin as topical treatment or supplement with orally administered amoxicillin/clavulanic acid in the treatment of more severe cases. The supply of topical agents in Luanda is unknown; therefore, the optimal treatment of patients colonized with A. faecalis should be determined and appropriate supplies obtained.
Dr. Filipe is a specialist in otorhinolaryngology (ENT) who has served for more than 25 years as a director of ENT at Hospital Josina Machel and head of the department of ENT at the medical faculty in Luanda (Angola). His primary research interest is the bacteriology and epidemiology of CSOM.
Acknowledgment
This work was supported by grants from Foundations of Anna and Edwin Berger (to K.R.) and Gyllenstierna-Krapperup (to K.R. and Å.R.), as well as the Swedish Medical Research Council (grant no. K2015-57X-03163-43-4), and Skåne County Council’s research and development foundation (to K.R.). Support was also obtained from Päivikki and Sakari Sohlberg Foundation (to T.P.), and the Paediatric Research Foundation (Helsinki, Finland) (to T.P.).
References
- Koch A, Homøe P, Pipper C, Hjuler T, Melbye M. Chronic suppurative otitis media in a birth cohort of children in Greenland: population-based study of incidence and risk factors. Pediatr Infect Dis J. 2011;30:25–9. DOIPubMedGoogle Scholar
- Acuin J. Chronic supprative otitis media. Burden of illness and management options. Geneva: World Health Organization; 2004 [cited 2017 Aug 16]. http://www.who.int/pbd/publications/Chronicsuppurativeotitis_media.pdf
- Aduda DS, Macharia IM, Mugwe P, Oburra H, Farragher B, Brabin B, et al. Bacteriology of chronic suppurative otitis media (CSOM) in children in Garissa district, Kenya: a point prevalence study. Int J Pediatr Otorhinolaryngol. 2013;77:1107–11. DOIPubMedGoogle Scholar
- Bizet J, Bizet C. Strains of Alcaligenes faecalis from clinical material. J Infect. 1997;35:167–9. DOIPubMedGoogle Scholar
- Kahveci A, Asicioglu E, Tigen E, Ari E, Arikan H, Odabasi Z, et al. Unusual causes of peritonitis in a peritoneal dialysis patient: Alcaligenes faecalis and Pantoea agglomerans. Ann Clin Microbiol Antimicrob. 2011;10:12. DOIPubMedGoogle Scholar
- Pal SS, Panigrahi PK, Roy R, Nandi K, Das S. Endophthalmitis caused by Alcaligenes faecalis: a case series. Ocul Immunol Inflamm. 2013;21:446–8. DOIPubMedGoogle Scholar
- Gerlach H. Bacteria. In: Ritchie BW, Harrison GJ, Harrison LR, editors. Avian medicine: principles and applications. Lake Worth (FL, USA): Wingers Publishing; 1994. p. 949–83 [cited 2017 Aug 16]. http://avianmedicine.net/content/uploads/2013/03/33.pdf
- Kaijalainen T, Ruokokoski E, Ukkonen P, Herva E. Survival of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis frozen in skim milk- tryptone-glucose-glycerol medium. J Clin Microbiol. 2004;42:412–4. DOIPubMedGoogle Scholar
- Obi CL, Enweani IB, Giwa JO. Bacterial agents causing chronic suppurative otitis media. East Afr Med J. 1995;72:370–2.PubMedGoogle Scholar
- Mittal R, Lisi CV, Gerring R, Mittal J, Mathee K, Narasimhan G, et al. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media. J Med Microbiol. 2015;64:1103–16. DOIPubMedGoogle Scholar
Table
Cite This ArticleTable of Contents – Volume 23, Number 10—October 2017
EID Search Options |
---|
|
|
|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Kristian Riesbeck, Clinical Microbiology, Dept. of Translational Medicine, Faculty of Medicine, Lund University, Jan Waldenströms gata 59, SE20502 Malmö, Sweden
Top